🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the efficacy and safety of sitravat...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-06-30
Trial ID
NCT05564338
Treatments Being Tested
The purpose of this study is to evaluate Sitravatinib, an oral small molecu...
Status
Completed
Location
Massachussetts General Hospital
Start Date
2016-11
Trial ID
NCT02978859
Treatments Being Tested
SITISVEAL stablish the hypothesis that treatment with Tislelizumab + Sitrav...
Status
Completed
Location
Hospital Universitario Virgen de la Macarena
Start Date
2022-09-23
Trial ID
NCT05542342
Treatments Being Tested
A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild, Mo...
Status
Completed
Location
Orange County Research Center
Start Date
2021-03-12
Trial ID
NCT04772612
Treatments Being Tested
The study will evaluate the clinical activity of PD-(L)1 Checkpoint Inhibit...
Status
Terminated
Location
The University of Arizona Cancer Center
Start Date
2018-09-11
Trial ID
NCT03606174
Treatments Being Tested
A Phase 1 Open-label, Two-cohort, One-sequence Crossover Study to Investiga...
Status
Completed
Location
Labcorp Drug Development Clinical Research Unit
Start Date
2022-02-02
Trial ID
NCT05255276
Treatments Being Tested
This is a window of opportunity study for patients with resectable squamous...
Status
Completed
Location
Princess Margaret Cancer Centre
Start Date
2018-08-30
Trial ID
NCT03575598
Treatments Being Tested
This is an open label, multi-center, single arm study to evaluate the effic...
Status
Unknown
Location
Anhui province hospital
Start Date
2022-07-25
Trial ID
NCT05407519
Treatments Being Tested
This is open-label, phase II study enrolling advanced BTC patients who have...
Status
Unknown
Location
Seoul National University Hospital
Start Date
2020-11-01
Trial ID
NCT04727996
Treatments Being Tested
This study evaluates the efficacy of sitravatinib in patients with metastat...
Status
Terminated
Location
Baylor College of Medicine
Start Date
2021-09-22
Trial ID
NCT04123704
Treatments Being Tested